TriSalus Life Sciences Inc
NASDAQ:TLSI
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.62
10.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
TLSI Price Targets Summary
TriSalus Life Sciences Inc
According to Wall Street analysts, the average 1-year price target for TLSI is 12.16 USD with a low forecast of 10.1 USD and a high forecast of 16.8 USD.
TLSI Last Price Targets
TriSalus Life Sciences Inc
The latest public price target was made on Nov 15, 2024 by
William Plovanic
from
Canaccord Genuity
,
who expects
TLSI
stock to
rise by 148%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
William Plovanic
Canaccord Genuity
|
11
USD
Upside 148% |
1 week ago
Nov 15, 2024
|
TriSalus Life Sciences, Inc. (TLSI) PT Lowered to $11 at Canaccord Genuity
StreetInsider
|
Suraj Kalia
Oppenheimer
|
10
USD
Upside 126% |
2 months ago
Sep 16, 2024
|
Oppenheimer Starts TriSalus Life Sciences, Inc. (TLSI) at Outperform, PT $10
StreetInsider
|
|
William Plovanic
Canaccord Genuity
|
12
USD
Upside 171% |
4 months ago
Jul 2, 2024
|
Canaccord Genuity Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TLSI's stock price target?
Price Target
12.16
USD
According to Wall Street analysts, the average 1-year price target for TLSI is 12.16 USD with a low forecast of 10.1 USD and a high forecast of 16.8 USD.
What is TriSalus Life Sciences Inc's Revenue forecast?
Projected CAGR
49%
The compound annual growth rate of TriSalus Life Sciences Inc's revenue for the next 3 years is 49%.
You don't have any saved screeners yet
